SCHEDULE: Manulife Adjusts Xperi Stake in Schedule 13G Filing

Manulife Financial Corporation and its subsidiaries have filed an amendment to their Schedule 13G, reporting changes in their beneficial ownership of Xperi Inc. common stock.

Summary

• This filing is an amendment (Amendment No. 4) to a Schedule 13G, indicating a change in beneficial ownership of Xperi Inc. common stock.
• The reporting persons are Manulife Financial Corporation (MFC), Manulife Investment Management Limited (MIML), and Manulife Investment Management (US) LLC (MIM (US)).
• MIM (US) holds 3,083,845 shares, representing 6.39% of the class.
• MIML holds 8,571 shares, representing 0.02% of the class.
• MFC may be deemed to have beneficial ownership of these shares through its parent-subsidiary relationship with MIM (US) and MIML.
• The filing reports the aggregate amount beneficially owned by each reporting person and the percentage of the class represented by that amount.
• The date of the event requiring this filing is June 30, 2026.

Sentiment

Score: 3

Explanation: StockSavvy.ai views this filing as having a neutral to slightly negative sentiment due to its nature as an amendment to a Schedule 13G, primarily reporting changes in beneficial ownership rather than new operational or financial performance data.

Positives

• Manulife entities continue to hold a significant stake in Xperi Inc., with MIM (US) holding 6.39% of the common stock.
• The filing provides clear disclosure of beneficial ownership, adhering to regulatory requirements.

Negatives

• The filing does not contain new financial performance data or strategic updates for Xperi Inc., focusing solely on ownership changes.
• The aggregate beneficial ownership reported by MFC is 0.00 shares, which may be confusing without understanding the subsidiary reporting structure.

Risks

• Changes in beneficial ownership, even if minor, can sometimes signal shifts in investor sentiment or strategy, though this filing appears to be an administrative update.
• The filing does not provide forward-looking statements or insights into Xperi's future performance, limiting its predictive value.

Future Outlook

This filing is an amendment to a Schedule 13G and does not contain forward-looking statements or guidance regarding Xperi Inc.'s future performance.

Management Comments

• "Signed pursuant to a Power of Attorney dated January 17, 2018 included as Exhibit A to Schedule 13F- NT filed with the Securities and Exchange Commission by Manulife Financial Corporation on January 29, 2018."
• "By signing below I certify that, to the best of my knowledge and belief, the foreign regulatory scheme applicable to MIML is substantially comparable to the regulatory scheme applicable to the functionally equivalent U.S. institution(s)."
• "I also undertake to furnish to the Commission staff, upon request, information that would otherwise be disclosed in a Schedule 13D."
• "After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct."

Industry Context

StockSavvy.ai notes that Schedule 13G filings are routine disclosures for institutional investors exceeding a certain ownership threshold. This filing indicates Manulife's ongoing, albeit passive, investment in Xperi Inc. within the semiconductor and technology licensing sector.

Stakeholder Impact

• Shareholders: The filing provides transparency regarding significant institutional ownership, which can influence market perception.
• Regulators: Ensures compliance with SEC disclosure requirements for beneficial ownership.

Next Steps

• Manulife entities will continue to monitor their beneficial ownership of Xperi Inc. common stock and file amendments to Schedule 13G as required by regulatory changes in ownership.

Key Dates

Keywords

Schedule 13G, Beneficial Ownership, Manulife, Xperi Inc., Investment Management, Amendment, Common Stock, SEC Filing